362 related articles for article (PubMed ID: 31470785)
1. Single Stranded DNA Immune Modulators with Unmethylated CpG Motifs: Structure and Molecular Recognition by Toll-Like Receptor 9.
Fehér K
Curr Protein Pept Sci; 2019; 20(11):1060-1068. PubMed ID: 31470785
[TBL] [Abstract][Full Text] [Related]
2. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
Yu C; An M; Li M; Liu H
Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
Front Immunol; 2019; 10():179. PubMed ID: 30800129
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation.
Jurk M; Vollmer J
BioDrugs; 2007; 21(6):387-401. PubMed ID: 18020622
[TBL] [Abstract][Full Text] [Related]
5. Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.
Meng W; Yamazaki T; Nishida Y; Hanagata N
BMC Biotechnol; 2011 Sep; 11():88. PubMed ID: 21943407
[TBL] [Abstract][Full Text] [Related]
6. Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.
Hanagata N
Int J Nanomedicine; 2012; 7():2181-95. PubMed ID: 22619554
[TBL] [Abstract][Full Text] [Related]
7. Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9.
Pohar J; Lainšček D; Fukui R; Yamamoto C; Miyake K; Jerala R; Benčina M
J Immunol; 2015 Nov; 195(9):4396-405. PubMed ID: 26416273
[TBL] [Abstract][Full Text] [Related]
8. Minimal sequence requirements for oligodeoxyribonucleotides activating human TLR9.
Pohar J; Kužnik Krajnik A; Jerala R; Benčina M
J Immunol; 2015 Apr; 194(8):3901-8. PubMed ID: 25780037
[TBL] [Abstract][Full Text] [Related]
9. Short single-stranded DNA degradation products augment the activation of Toll-like receptor 9.
Pohar J; Lainšček D; Ivičak-Kocjan K; Cajnko MM; Jerala R; Benčina M
Nat Commun; 2017 May; 8():15363. PubMed ID: 28530246
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 9 and 21 have different ligand recognition profiles and cooperatively mediate activity of CpG-oligodeoxynucleotides in zebrafish.
Yeh DW; Liu YL; Lo YC; Yuh CH; Yu GY; Lo JF; Luo Y; Xiang R; Chuang TH
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20711-6. PubMed ID: 24282308
[TBL] [Abstract][Full Text] [Related]
11. Toll-Like Receptor 21 of Chicken and Duck Recognize a Broad Array of Immunostimulatory CpG-oligodeoxynucleotide Sequences.
Chuang YC; Tseng JC; Yang JX; Liu YL; Yeh DW; Lai CY; Yu GY; Hsu LC; Huang CM; Chuang TH
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33147756
[TBL] [Abstract][Full Text] [Related]
12. Selectivity of Human TLR9 for Double CpG Motifs and Implications for the Recognition of Genomic DNA.
Pohar J; Yamamoto C; Fukui R; Cajnko MM; Miyake K; Jerala R; Benčina M
J Immunol; 2017 Mar; 198(5):2093-2104. PubMed ID: 28115525
[TBL] [Abstract][Full Text] [Related]
13. Prediction of novel mouse TLR9 agonists using a random forest approach.
Khanna V; Li L; Fung J; Ranganathan S; Petrovsky N
BMC Mol Cell Biol; 2019 Dec; 20(Suppl 2):56. PubMed ID: 31856726
[TBL] [Abstract][Full Text] [Related]
14. Cytosine-phosphate-guanine oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by keyhole limpet hemocyanin antigen in dairy cattle.
Chu CY; Lee SC; Liu SS; Lin YM; Shen PC; Yu C; Lee KH; Zhao X; Lee JW
Nucleic Acid Ther; 2011 Oct; 21(5):323-32. PubMed ID: 21916610
[TBL] [Abstract][Full Text] [Related]
15. CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responses.
Yeh DW; Lai CY; Liu YL; Lu CH; Tseng PH; Yuh CH; Yu GY; Liu SJ; Leng CH; Chuang TH
Sci Rep; 2017 Dec; 7(1):17297. PubMed ID: 29229937
[TBL] [Abstract][Full Text] [Related]
16. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.
Yasuda K; Rutz M; Schlatter B; Metzger J; Luppa PB; Schmitz F; Haas T; Heit A; Bauer S; Wagner H
Eur J Immunol; 2006 Feb; 36(2):431-6. PubMed ID: 16421948
[TBL] [Abstract][Full Text] [Related]
17. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
Suwarti S; Yamazaki T; Svetlana C; Hanagata N
Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
[TBL] [Abstract][Full Text] [Related]
18. Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.
Wu CC; Lee J; Raz E; Corr M; Carson DA
J Biol Chem; 2004 Aug; 279(32):33071-8. PubMed ID: 15184382
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 9 interaction with CpG ODN--an in silico analysis approach.
Zhou W; Li Y; Pan X; Gao Y; Li B; Qiu Z; Liang L; Zhou H; Yue J
Theor Biol Med Model; 2013 Mar; 10():18. PubMed ID: 23497207
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
